Loading data for ZSTK — first visit, this takes a few seconds.

ZeroStack Corp.

NasdaqCM: ZSTK · Real-Time Price · USD
5.00
-0.28 (-5.30%)
At close: Sep 01, 2026, 11:52 AM

The price, the headline numbers and the latest news, in one place.

ZeroStack Corp. (ZSTK) Stock Price, Analysis & Data

-5.40% (1D)
Bid4.42
Market Cap90.8M
Revenue (ttm)40M
Net Income (ttm)-175M
1.71
-44.52
n/a
n/a
P/B (ttm)0.91
P/S (ttm)2.27
Earnings Daten/a
Ask6.11
Volume87,139
Avg. Volume (20D)459,790
Open5.34
Previous Close5.28
Day's Range4.71 - 5.38
52-Week Range1.32 - 47.00
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About ZSTK

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates...

IPO Date May 11, 2021
Employees 21
Stock Exchange NasdaqCM
Ticker Symbol ZSTK
Full Company Profile

Financial Performance

In 2025, ZeroStack's revenue was 35.68M, a decrease of -0.53% compared to the previous year's 35.87M. Earnings were -119.73M, an increase of 652.7%.

Financial Statements

Earnings Surprise

ZeroStack has released their quarterly earnings on Jul 31, 2026:
  • Revenue of $13.66M misses estimates by $0, with 40.67% YoY growth.
  • EPS of -2.47 misses estimates by -2.36, with 45.59% YoY growth.